Is NASDAQ:MEDP suited for growth investing?

In this article we will dive into MEDPACE HOLDINGS INC (NASDAQ:MEDP) as a possible candidate for growth investing. Investors should always do their own research, but we noticed MEDPACE HOLDINGS INC showing up in our CANSLIM growth screen, which makes it worth to investigate a bit more.

Some of the canslim metrics of NASDAQ:MEDP highlighted

• The recent financial report of MEDPACE HOLDINGS INC demonstrates a 32.19% increase in quarterly earnings compared to the previous quarter. This growth indicates positive momentum in the company's financials and suggests a promising upward trend
• The recent q2q revenue growth of 31.22% of MEDPACE HOLDINGS INC showcases the company's ability to generate increasing revenue in a short period, reflecting its positive growth trajectory.
• MEDPACE HOLDINGS INC has experienced 34.48% growth in EPS over a 3-year period, demonstrating its ability to generate sustained and positive earnings momentum.
• In terms of Return on Equity(ROE), MEDPACE HOLDINGS INC is performing well, achieving a 68.65% ratio. This highlights the company's effective allocation of shareholder investments and signifies its commitment to maximizing returns.
• The Relative Strength (RS) of MEDPACE HOLDINGS INC has been consistently solid, with a current 97.07 rating. This highlights the stock's ability to exhibit sustained price strength and signifies its competitive advantage. MEDPACE HOLDINGS INC exhibits strong prospects for further price appreciation.
• With a current Debt-to-Equity ratio at 0.14, MEDPACE HOLDINGS INC showcases its disciplined capital structure. The company's prudent management of debt obligations contributes to its financial stability and long-term sustainability.
• With 77.02% of the total shares held by institutional investors, MEDPACE HOLDINGS INC showcases a healthy distribution of ownership. This suggests a mix of institutional and retail investors, fostering a dynamic market for the stock.

What is the technical picture of NASDAQ:MEDP telling us.

ChartMill assigns a Technical Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple technical indicators and properties.

Overall MEDP gets a technical rating of 10 out of 10. This is due to a consistent performance in both the short and longer term time frames. Also compared to the overall market, MEDP is showing a nice and steady performance.

• The long and short term trends are both positive. This is looking good!
• Looking at the yearly performance, MEDP did better than 97% of all other stocks. On top of that, MEDP also shows a nice and consistent pattern of rising prices.
• MEDP is one of the better performing stocks in the Life Sciences Tools & Services industry, it outperforms 95% of 63 stocks in the same industry.
• MEDP is currently making a new 52 week high. This is a strong signal. The S&P500 Index however is also trading near new highs, which makes the performance in line with the market.
• In the last month MEDP has a been trading in the 244.69 - 274.62 range, which is quite wide. It is currently trading near the high of this range.

Our latest full technical report of MEDP contains the most current technical analsysis.

Zooming in on the fundamentals.

ChartMill assigns a Fundamental Rating to every stock. This score ranges from 0 to 10 and is updated daily. The score is determined by evaluating multiple fundamental indicators and properties.

MEDP gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 63 industry peers in the Life Sciences Tools & Services industry. MEDP has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MEDP is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, MEDP could be worth investigating further for growth and quality investing!.

For an up to date full fundamental analysis you can check the fundamental report of MEDP

More growth stocks can be found in our CANSLIM screen.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.